[EN] Swiss Medical Cannabis : PhytoXtract SA is the 1st Laboratory to be granted GMP/GDP authorisations in Romandy, Switzerland.

Plan-les-Ouates, 05.01.2021 – PhytoXtract SA is granted both GMP (Good Manufacturing Practices) and GDP (Good Distribution Practices) from Swissmedic – Swiss Agency for Therapeutic Products. This opens the floor to an increased medical cannabis supply for the Pharmacies in sub-contracting their CBD/THC preparations. The quality management system in place offers a wide range of formulations; pure CBD/THC, broad/full spectrum to customized orders.

Contacts:

• Contact for Pharmacies : b2b@phytoxtract.ch
• Media Contact : media@phytoxtract.ch

PhytoXtract SA, ch des Aulx 14, 1228 Plan-les-Ouates